November 27, 2023
Teva Pharmaceuticals International GmbH has moved in Massachusetts federal court to permanently drop an infringement case against Eli Lilly and Co. over a migraine drug — an action taken after the Patent Trial and Appeal Board found two patents related to the drug and its use invalid.
March 15, 2022
A Massachusetts federal judge refused on Tuesday to boot Teva Pharmaceutical's patent suit against rival Eli Lilly over a competing migraine medication, ruling that Eli Lilly was relying on claim construction arguments that were inappropriate at this early stage of the case.
October 19, 2021
Teva Pharmaceuticals says that Eli Lilly shouldn't be able to dodge a suit alleging an Eli Lilly migraine drug infringes a pair of Teva patents, arguing that the complaint is adequately pled.
June 08, 2021
Teva Pharmaceuticals lodged a new infringement suit against rival Eli Lilly in Massachusetts federal court Tuesday mere hours after the U.S. Patent and Trademark Office issued the company two new patents covering the Israeli drugmaker's blockbuster migraine drug Ajovy.